Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Hulshof, M C C M"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vernooij, R. W. M., Cremers, R. G. H. M., Jansen, H., Somford, D. M., Kiemeney, L. A., van Andel, G., Wijsman, B. P., Busstra, M. B., van Moorselaar, R. J. A., Wijnen, E. M., Pos, F. J., Hulshof, M. C. C. M., Hamberg, P., van den Berkmortel, F., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., F€utterer, J. J., van Oort, I. M., Aben, K. K. H.
Publikováno v:
Urologic Oncology: Seminars and Original Investigations, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.
The authors regret that the following statements were incorrectly mentioned in the paper. Page 4, line 333, paragraph 3.1. Descriptive statistics: “.2358.” should be 2538 Page 4, line 338-340, paragraph 3.1. Descriptive statistics: “.and were t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5db9ac6c33daac385d9187bc05ef619d
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3
Autor:
van Amelsfoort, R. M., Walraven, I., Kieffer, J., Jansen, E. P. M., Cats, A., van Grieken, N. C. T., Meershoek-Klein Kranenbarg, E., Putter, H., van Sandick, J. W., Sikorska, K., van de Velde, C. J. H., Aaronson, N. K., Verheij, M., Boot, H., Trip, A., van Coevorden, F., Vanhoutvin, S., Swellengrebel, H. A. M., Hulshof, M. C. C. M., van Berge Henegouwen, M. I., van Laarhoven, H. W. M., Loosveld, O. J. L., ten Tije, A. J., Erdkamp, F. L. G., Warmerdam, F. A. R. M., van der Peet, D. L., Verheul, H. M. W., Portielje, J. E. A., Spillenaar Bilgen, E. J., Poleé, M. B., Geenen, M. M., Neelis, K. J., Slingerland, M., Jansen, R. L. H., van Spronsen, D. J., Tanis, B. C., van Hillegersberg, R., Koopman, M., den Boer, M. O., Creemers, G. J., van den Berg, H. P., Baars, A., Appels, M. I. E., Smit, J. M., Muller, E. W., de Boer, J., van Dijk, M. A., van der Gaast, A., Otten, J. M. M. B., Ceha, H. M.
Publikováno v:
Journal of the National Comprehensive Cancer Network, 20(3), 261-267. Cold Spring Publishing LLC
van Amelsfoort, R M, Walraven, I, Kieffer, J, Jansen, E P M, Cats, A, van Grieken, N C T, Meershoek-Klein Kranenbarg, E, Putter, H, van Sandick, J W, Sikorska, K, van de Velde, C J H, Aaronson, N K, Verheij, M & CRITICS investigators 2022, ' Quality of Life Is Associated With Survival in Patients With Gastric Cancer : Results From the Randomized CRITICS Trial ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 261-267 . https://doi.org/10.6004/JNCCN.2021.7057
Journal of the National Comprehensive Cancer Network, 20, 261-267
JNCCN Journal of the National Comprehensive Cancer Network, 20(3), 261-267. Cold Spring Publishing LLC
CRITICS investigators 2022, ' Quality of Life Is Associated With Survival in Patients With Gastric Cancer : Results From the Randomized CRITICS Trial ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 261-267 . https://doi.org/10.6004/JNCCN.2021.7057
Journal of the National Comprehensive Cancer Network, 20(3), 261-+. HARBORSIDE PRESS
Journal of the National Comprehensive Cancer Network, 20, 3, pp. 261-267
van Amelsfoort, R M, Walraven, I, Kieffer, J, Jansen, E P M, Cats, A, van Grieken, N C T, Meershoek-Klein Kranenbarg, E, Putter, H, van Sandick, J W, Sikorska, K, van de Velde, C J H, Aaronson, N K, Verheij, M & CRITICS investigators 2022, ' Quality of Life Is Associated With Survival in Patients With Gastric Cancer : Results From the Randomized CRITICS Trial ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 261-267 . https://doi.org/10.6004/JNCCN.2021.7057
Journal of the National Comprehensive Cancer Network, 20, 261-267
JNCCN Journal of the National Comprehensive Cancer Network, 20(3), 261-267. Cold Spring Publishing LLC
CRITICS investigators 2022, ' Quality of Life Is Associated With Survival in Patients With Gastric Cancer : Results From the Randomized CRITICS Trial ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 3, pp. 261-267 . https://doi.org/10.6004/JNCCN.2021.7057
Journal of the National Comprehensive Cancer Network, 20(3), 261-+. HARBORSIDE PRESS
Journal of the National Comprehensive Cancer Network, 20, 3, pp. 261-267
Background: The evaluation of health-related quality of life (HRQoL) in clinical trials has become increasingly important because it addresses the impact of treatment from the patient’s perspective. The primary aim of this study was to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::189314f1b074732e8a27a223d95932a8
https://pure.amc.nl/en/publications/quality-of-life-is-associated-with-survival-in-patients-with-gastric-cancer(b2925df0-03ba-4619-af92-b3eb6710ff6c).html
https://pure.amc.nl/en/publications/quality-of-life-is-associated-with-survival-in-patients-with-gastric-cancer(b2925df0-03ba-4619-af92-b3eb6710ff6c).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.
Additional file 1: Figure S1. Poor responder phenotype in patient samples. A Pathway signal transduction activity of six key signal transduction pathways was measured in the resectable disease cohort (i). Pre-treatment biopsy pathway activity scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ecaec57f6910beca0af6208061f860
Autor:
Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.
Additional file 3: Figure S3. PI3K inhibitors can revert CRT-induced EMT. A Correlation of gene expression of Broad Hallmark Pi3K_AKT_mTor_signalling gene set with the Broad Hallmark Epithelial_Mesenchymal_transition gene set in two publicly availabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0662b6dae0984126dd37b926ab2660
Autor:
Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.
Additional file 5: Table S1. Characteristics of the five established patient derived cell lines. Table S2. FDA approved PI3K inhibitors tested in this study. Table S3 Western blot antibodies used in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9691a78f8582b6ea5fbf901ba6066fb3
Autor:
Creemers, A., van der Zalm, A. P., van de Stolpe, A., Holtzer, L., Stoffels, M., Hooijer, G. K. J., Ebbing, E. A., van Ooijen, H., van Brussel, A. G. C., Aussems-Custers, E. M. G., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., Bergman, J. J. G. H. M., Meijer, S. L., Bijlsma, M. F., van Laarhoven, H. W. M.
Additional file 4: Figure S4. Apoptosis induced by PI3K pathway inhibitors in poor responder CRT cell lines. Poor CRT responder cell lines 007B, 058 M and 081R and good responder cell lines Flo1, OE19 and OE33 were treated for 7 days with the CRT reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8c467169ad808a897a3fe8555ecfca
Autor:
Ripping, T. M., Rammant, E., Witjes, J. A., Aaronson, N. K., van Hemelrijck, M., van Hoogstraten, L. M. C., BlaZIB study group, Boormans, J., Goossens, C. A., van der Heijden, A. G., Hulshof, M. C. C. M., van Leenders, G. J. L. H., van Leliveld, A. M., Meijer, R. P., van Moorselaar, R. J. A., Mulder, S. F., Nooter, R. I., Noteboom, J. L., Oddens, J. R., de Reijke, T. M.
Publikováno v:
Health & Quality of Life Outcomes; 12/29/2022, Vol. 20 Issue 1, p1-12, 12p
Autor:
Ykema, Berbel L. M., Hoefnagel, Sanne J. M., Rigter, Lisanne S., Kodach, Liudmila L., Meijer, Gerrit A., van Leeuwen, Flora E., Khan, Hina N., Snaebjornsson, Petur, Aleman, Berthe M. P., Broeks, Annegien, Meijer, Sybren L., Wang, Kenneth K., Carvalho, Beatriz, Krishnadath, Kausilia K., vanLeerdam, Monique E., Meijer, S. L., Hulshof, M. C. C. M., Geijsen, E. D., van Laarhoven, H. W. M., van Berge Henegouwen, M. I., Gisbertz, S. S.
Publikováno v:
PLoS ONE
PLoS ONE, 15(12). PUBLIC LIBRARY SCIENCE
PLoS ONE, 15(12 December):e0243178. Public Library of Science
PLoS ONE, Vol 15, Iss 12, p e0243178 (2020)
on behalf of GIOCA-OES¶ 2020, ' Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases ', PLoS ONE, vol. 15, no. 12 December, e0243178 . https://doi.org/10.1371/journal.pone.0243178
PLoS ONE, 15(12). PUBLIC LIBRARY SCIENCE
PLoS ONE, 15(12 December):e0243178. Public Library of Science
PLoS ONE, Vol 15, Iss 12, p e0243178 (2020)
on behalf of GIOCA-OES¶ 2020, ' Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases ', PLoS ONE, vol. 15, no. 12 December, e0243178 . https://doi.org/10.1371/journal.pone.0243178
Hodgkin lymphoma (HL) survivors are at increased risk of developing second primary esophageal squamous cell cancer (ESCC). We aimed to gain insight in the driving events of ESCC in HL survivors (hESCC) by using RNA sequencing and NanoString profiling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df416bc96348861e6b694920d654b6e
http://europepmc.org/articles/PMC7751872
http://europepmc.org/articles/PMC7751872